TD Cowen lowered the firm’s price target on Privia Health to $26 from $30 and keeps an Outperform rating on the shares. The firm said Q23 results and 2024 guide were modestly below consensus though not as bad as feared.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on PRVA:
